Literature DB >> 17943239

Dicarbonyl-mediated protein modifications affect matrix metalloproteinase (MMP) activity.

B Bartling1, M Desole, R-E Silber, A Simm.   

Abstract

Advanced age is linked with an increased incidence of epithelial tumours (carcinomas) including lung tumours. However, a slowing rate of the increase of age-specific cancer incidence is demonstrated at very advanced ages, and elderly patients also develop less invasive and metastatic tumours than their younger counterparts. Matrix metalloproteinases (MMPs) are commonly upregulated in the stromal compartment of the carcinoma tissue and are believed to promote invasion and metastasis. As the increased serum and tissue level of advanced glycation end products (AGEs) is a characteristic feature of old humans, our study focused on the impact of AGEs on the activity of MMPs released from lung fibroblasts (WI- 38). The collagen gel zymography technique showed the primary presence of MMP-2 in the conditioned medium of the WI-38 fibroblasts, which was even higher in senescent WI-38 fibroblasts. Subsequent treatment of the WI- 38 conditioned medium with the dicarbonyl compound glyoxal, a highly reactive precursor of the AGE formation, resulted in a dose-dependent reduction of the MMP-2 activity. Therefore, our study suggests that the age-associated increase in AGEs might be one potential host factor responsible for the less invasiveness of tumours at very advanced age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943239     DOI: 10.1007/s00391-007-0485-8

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  27 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 2.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Authors:  Robert Visse; Hideaki Nagase
Journal:  Circ Res       Date:  2003-05-02       Impact factor: 17.367

Review 3.  Advanced glycation end products in uremia.

Authors:  Thomas Henle; Toshio Miyata
Journal:  Adv Ren Replace Ther       Date:  2003-10

Review 4.  The Maillard reaction in vivo.

Authors:  D G Dyer; J A Blackledge; B M Katz; C J Hull; H D Adkisson; S R Thorpe; T J Lyons; J W Baynes
Journal:  Z Ernahrungswiss       Date:  1991-02

5.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.

Authors:  P J Thornalley; A Langborg; H S Minhas
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

6.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

Review 7.  Gelatinase-mediated migration and invasion of cancer cells.

Authors:  Mikael Björklund; Erkki Koivunen
Journal:  Biochim Biophys Acta       Date:  2005-04-12

8.  B16 murine melanoma and aging: slower growth and longer survival in old mice.

Authors:  W B Ershler; J A Stewart; M P Hacker; A L Moore; B H Tindle
Journal:  J Natl Cancer Inst       Date:  1984-01       Impact factor: 13.506

9.  Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons.

Authors:  H Niwa; A Takeda; M Wakai; T Miyata; Y Yasuda; T Mitsuma; K Kurokawa; G Sobue
Journal:  Biochem Biophys Res Commun       Date:  1998-07-09       Impact factor: 3.575

10.  Modification and inactivation of human Cu,Zn-superoxide dismutase by methylglyoxal.

Authors:  Jung Hoon Kang
Journal:  Mol Cells       Date:  2003-04-30       Impact factor: 5.034

View more
  2 in total

Review 1.  Cellular senescence in normal and premature lung aging.

Authors:  B Bartling
Journal:  Z Gerontol Geriatr       Date:  2013-10       Impact factor: 1.281

2.  Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma.

Authors:  Babett Bartling; Hans-Stefan Hofmann; Antonia Sohst; Yvonne Hatzky; Veronika Somoza; Rolf-Edgar Silber; Andreas Simm
Journal:  Mol Med       Date:  2011-05-24       Impact factor: 6.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.